Frequently asked questions
What stage of companies does JardineLabs typically work with?
We support deep tech ventures from concept validation through Series A, with specialized programs for each stage of development.
How does JardineLabs differ from traditional tech incubators?
Unlike general incubators, we focus exclusively on deep tech with dedicated AI, robotics, and sustainability labs, plus technical experts who understand complex commercialization challenges.
What's the typical timeline for companies in your program?
Do you provide funding in addition to mentorship and resources?
Yes, we offer seed funding up to $500K for selected ventures, plus connections to our extensive investor network for follow-on rounds.
What makes a deep tech venture qualified for JardineLabs programs?
We look for ventures with defensible technological innovation, strong intellectual property, and potential for significant market disruption. Ideal candidates have a working prototype or proof-of-concept, a technical founding team, and a clear path to commercialization within 18-24 months.
How much equity does JardineLabs typically take?
Our equity requirements vary by program stage and funding provided. Seed stage programs typically require 6-8% equity, while growth stage programs range from 8-12%. We maintain transparent, founder-friendly terms and provide significant value through our comprehensive support ecosystem.
Can international companies apply to JardineLabs?
Absolutely! We welcome applications from innovative deep tech companies worldwide. We provide visa support for international founders, help establish US operations, and navigate regulatory requirements for international technology transfer and market entry.
Do you accept solo founders, or do we need a complete team?
While we prefer teams with complementary skills, we do accept exceptional solo founders. In these cases, we provide team-building support through our talent network, help identify co-founders or key hires, and offer additional mentorship to fill skill gaps during the critical early stages.